Joseph H. Antin
Chief and Program Director
Hematologic OncologyÂ
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Antin received his MD from Cornell University in 1978, and postgraduate training in hematology and medical oncology at DFCI and Brigham and Women's Hospital. He subsequently served as director of the Bone Marrow Transplantation Service at BWH from 1987 to 1997. He now heads the Stem Cell Transplant Program of the Department of Medical Oncology at DFCI and BWH. He is a founding member and past president of the American Society of Blood and Marrow Transplantation and a past Chairman of the Steering Committee of the BMT Clinical Trial Network.
Research Interest
Stem cell/bone marrow transplantation, Aplastic anemia, Paroxysmal nocturnal hemoglobinuria (PNH), Bone marrow failure, Graft-versus-host disease and Graft-versus-leukemia
Publications
-
EDMUND, D., PELLEGRINO, M., KILNER, J. F., LINDA, K. B., & MITCHELL, C. (2002). Therapeutic Cloning. N Engl J Med, 346, 1576-9.
-
Antin, J. H. (2005). Approaches to graftâ€vsâ€host disease. Pediatric transplantation, 9(s7), 71-75.
-
Antin, J. H. (2005). Approaches to graftâ€vsâ€host disease. Pediatric transplantation, 9(s7), 71-75.
